Evaluation and Treatment of Hypertension in End-Stage Renal Disease Patients on Hemodialysis

Research output: Contribution to journalReview articlepeer-review

5 Scopus citations


Hypertension is one of the most common cardiovascular comorbidities in end-stage renal disease patients on hemodialysis. Its complex pathophysiology is related to extracellular volume overload, increased vascular resistance stemming from factors related to uremia or abnormal signaling from the failing kidneys, as well as the unique blood pressure changes that take place during and between hemodialysis treatments. Despite the changing nature of blood pressure over time in hemodialysis patients, hypertension diagnosed in or out of the hemodialysis unit is associated with increased cardiovascular morbidity and mortality. This review details the causes of hypertension in hemodialysis patients and provides an updated review of the clinical consequences and management of hypertension.

Original languageEnglish (US)
Article number125
JournalCurrent Cardiology Reports
Issue number12
StatePublished - Dec 1 2016


  • Dry weight
  • End-stage renal disease
  • Extracellular volume overload
  • Hemodialysis
  • Hypertension

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Evaluation and Treatment of Hypertension in End-Stage Renal Disease Patients on Hemodialysis'. Together they form a unique fingerprint.

Cite this